Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Assessment of the Cardiovascular System I: Subjective Data

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...

Coronary Artery Disease V: Interprofessional Care

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...

Coronary Artery Disease IV: Preventive Measures

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...

Pharmacovigilance

Pharmacovigilance

Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...

Acute Coronary Syndrome IV: Interprofessional Care

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Association of nurse-patient ratios with outcomes in patients on peritoneal dialysis.

Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis·2026

Same author

Methodological evaluation of the psychometric properties of medication-related quality indicators in residential aged care homes: a systematic review.

International journal for quality in health care : journal of the International Society for Quality in Health Care·2026

Same author

Epidemiology and characteristics of repeat adverse drug reactions and associated clinical outcomes in older adults: a systematic review and meta-analysis.

European geriatric medicine·2026

Same author

Hospitalisation as an Opportunity to Optimise Quality Use of Medicines in Older Adults: A Systematic Review.

Drugs & aging·2026

Same author

Implementing good life with OsteoArthritis from Denmark (GLA:D®) in public outpatient settings in Tasmania, Australia.

Osteoarthritis and cartilage open·2026

Same author

Angiotensin II-stimulating versus inhibiting antihypertensives and risk of dementia: a nested case-control study using Australian general practice data.

Scientific reports·2026

Search research articles

Related Experiment Video

Updated: Jun 15, 2026

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

Published on: September 26, 2018

Cardiovascular risk screening program in Australian community pharmacies.

Gregory M Peterson¹, Kimbra D Fitzmaurice, Helen Kruup

¹Unit for Medication Outcomes Research and Education, School of Pharmacy, University of Tasmania, Locked Bag 26, Hobart, TAS, 7001, Australia. G.Peterson@utas.edu.au

Pharmacy World & Science : PWS

|March 11, 2010

Summary

Community pharmacies can effectively screen for cardiovascular disease risk factors, identifying high-risk individuals for early intervention. This pharmacy-based program improves public knowledge and encourages lifestyle changes to reduce heart disease burden.

More Related Videos

A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program

A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program

Published on: April 19, 2019

Cholesterol Efflux Assay

Cholesterol Efflux Assay

Published on: March 6, 2012

Related Experiment Videos

Last Updated: Jun 15, 2026

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

Published on: September 26, 2018

A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program

A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program

Published on: April 19, 2019

Cholesterol Efflux Assay

Cholesterol Efflux Assay

Published on: March 6, 2012

Area of Science:

Public Health
Cardiovascular Medicine
Community Pharmacy Practice

Background:

Cardiovascular disease (CVD) is a leading cause of mortality globally.
Early detection and intervention are crucial for managing CVD risk factors.
Community pharmacies are accessible healthcare hubs with potential for public health screening.

Purpose of the Study:

To evaluate Australian community pharmacies as centers for CVD risk profiling.
To assess the role of community pharmacists in identifying, educating, and referring high-risk individuals.
To determine the impact of pharmacy-based screening on public knowledge of CVD risk factors.

Main Methods:

14 Australian community pharmacies participated in the study.
Opportunistic CVD risk profiling was conducted for individuals over 30 years old without existing CVD.
Risk factors were measured, 10-year CVD event risk calculated using Framingham Risk Equations, and knowledge assessed via questionnaire.

Main Results:

655 individuals were screened; 28.1% had a >15% 10-year CVD risk.
Elevated blood pressure, overweight/obesity, and dyslipidemia were prevalent.
Screening significantly improved knowledge of CVD risk factors, with high-risk individuals reporting lifestyle changes or initiating therapy.

Conclusions:

Pharmacy-based CVD risk screening and education programs can identify and refer undiagnosed high-risk individuals.
Community pharmacies are suitable centers for CVD risk profiling and intervention.
Such programs hold potential to mitigate the burden of heart disease.